ARAY
Price
$1.36
Change
-$0.01 (-0.73%)
Updated
Jul 25 closing price
Capitalization
244.95M
18 days until earnings call
ICUI
Price
$129.90
Change
+$0.71 (+0.55%)
Updated
Jul 25 closing price
Capitalization
2.55B
11 days until earnings call
Interact to see
Advertisement

ARAY vs ICUI

Header iconARAY vs ICUI Comparison
Open Charts ARAY vs ICUIBanner chart's image
Accuray
Price$1.36
Change-$0.01 (-0.73%)
Volume$510.55K
Capitalization244.95M
ICU Medical
Price$129.90
Change+$0.71 (+0.55%)
Volume$109.56K
Capitalization2.55B
ARAY vs ICUI Comparison Chart in %
Loading...
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARAY vs. ICUI commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a Hold and ICUI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ARAY: $1.36 vs. ICUI: $129.90)
Brand notoriety: ARAY and ICUI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ARAY: 56% vs. ICUI: 51%
Market capitalization -- ARAY: $244.95M vs. ICUI: $2.55B
ARAY [@Medical Specialties] is valued at $244.95M. ICUI’s [@Medical Specialties] market capitalization is $2.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileICUI’s FA Score has 1 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • ICUI’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARAY and ICUI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 6 TA indicator(s) are bullish while ICUI’s TA Score has 5 bullish TA indicator(s).

  • ARAY’s TA Score: 6 bullish, 2 bearish.
  • ICUI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ARAY is a better buy in the short-term than ICUI.

Price Growth

ARAY (@Medical Specialties) experienced а +1.87% price change this week, while ICUI (@Medical Specialties) price change was +6.07% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.01%. For the same industry, the average monthly price growth was +4.92%, and the average quarterly price growth was -2.24%.

Reported Earning Dates

ARAY is expected to report earnings on Oct 29, 2025.

ICUI is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Medical Specialties (+3.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICUI($2.55B) has a higher market cap than ARAY($245M). ICUI YTD gains are higher at: -16.285 vs. ARAY (-31.313). ICUI has higher annual earnings (EBITDA): 253M vs. ARAY (5.93M). ICUI has more cash in the bank: 255M vs. ARAY (72.8M). ARAY has less debt than ICUI: ARAY (202M) vs ICUI (1.7B). ICUI has higher revenues than ARAY: ICUI (2.26B) vs ARAY (447M).
ARAYICUIARAY / ICUI
Capitalization245M2.55B10%
EBITDA5.93M253M2%
Gain YTD-31.313-16.285192%
P/E RatioN/A333.33-
Revenue447M2.26B20%
Total Cash72.8M255M29%
Total Debt202M1.7B12%
FUNDAMENTALS RATINGS
ARAY vs ICUI: Fundamental Ratings
ARAY
ICUI
OUTLOOK RATING
1..100
2790
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8890
PRICE GROWTH RATING
1..100
6462
P/E GROWTH RATING
1..100
472
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARAY's Valuation (86) in the Medical Specialties industry is in the same range as ICUI (92). This means that ARAY’s stock grew similarly to ICUI’s over the last 12 months.

ARAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ICUI (100). This means that ARAY’s stock grew similarly to ICUI’s over the last 12 months.

ARAY's SMR Rating (88) in the Medical Specialties industry is in the same range as ICUI (90). This means that ARAY’s stock grew similarly to ICUI’s over the last 12 months.

ICUI's Price Growth Rating (62) in the Medical Specialties industry is in the same range as ARAY (64). This means that ICUI’s stock grew similarly to ARAY’s over the last 12 months.

ICUI's P/E Growth Rating (2) in the Medical Specialties industry is somewhat better than the same rating for ARAY (47). This means that ICUI’s stock grew somewhat faster than ARAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYICUI
RSI
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
63%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
65%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
68%
Advances
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 3 days ago
66%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 10 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BXXRF0.06N/A
N/A
Exgen Resources Inc.
DLNDY2.25N/A
N/A
D&L Industries, Inc.
KLBAY7.33N/A
N/A
Klabin S.A.
SSREF176.32N/A
N/A
Swiss Re Ltd
RHCCF0.01N/A
N/A
Royal Helium Limited

ICUI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with ALGN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
+0.55%
ALGN - ICUI
56%
Loosely correlated
N/A
CLPT - ICUI
56%
Loosely correlated
-0.44%
NVST - ICUI
53%
Loosely correlated
+0.63%
A - ICUI
49%
Loosely correlated
-0.14%
DHR - ICUI
47%
Loosely correlated
+1.32%
More